CIK: 0001056807 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $2,970,709 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRON | DISC MEDICINE INC | 650,000 | $51,617 | 1.7% | $84.50 | 0.0% | COM | 254604101 |
| IVVD | INVIVYD INC | 19,525,000 | $48,227 | 1.6% | $2.08 | 0.0% | COM | 00534A102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GPCR | STRUCTURE THERAPEUTICS INC | 3,479,022 (+8.6%) | $241,966 (+169.7%) | 8.1% | $34.45 | — | SPONSORED ADS | 86366E106 |
| XNCR | XENCOR INC | 7,133,720 (+160.3%) | $109,217 (+239.8%) | 3.7% | $17.12 | -12.7% | COM | 98401F105 |
| STOK | STOKE THERAPEUTICS INC | 2,265,674 (+36.7%) | $71,912 (+84.7%) | 2.4% | $20.61 | +45.9% | COM | 86150R107 |
| CMPX | COMPASS THERAPEUTICS INC | 7,764,842 (+63.5%) | $41,697 (+150.8%) | 1.4% | $3.73 | +24.0% | COM | 20454B104 |
| ANNX | ANNEXON INC | 9,128,080 (+30.4%) | $45,823 (+114.6%) | 1.5% | $2.79 | +37.1% | COM | 03589W102 |
| CBIO | CRESCENT BIOPHARMA INC. | 2,748,763 (+98.1%) | $32,600 (+97.6%) | 1.1% | $16.98 | -25.0% | COM | G2545C104 |
| NKTR | NEKTAR THERAPEUTICS | 1,559,595 (+22.2%) | $65,940 (-9.2%) | 2.2% | $37.25 | +50.2% | COM NEW | 640268306 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,560,916 | $170,122 | 5.7% | $29.18 | +180.5% | — | 74366E102 |
| — | CIDARA THERAPEUTICS INC | 1,414,165 | $135,420 | 4.6% | $51.89 | — | — | 171757206 |
| CELC | CELCUITY INC | 658,421 | $32,526 | 1.1% | $16.73 | +391.4% | — | 15102K100 |
| — | ESSA PHARMA INC | 11,668,473 | $2,229 | 0.1% | $2.79 | — | — | 29668H708 |
| SABS | SAB BIOTHERAPEUTICS INC | 932,697 | $1,875 | 0.1% | $5.45 | -39.7% | — | 78397T202 |
| FBRX | FORTE BIOSCIENCES INC | 65,350 | $980 | 0.0% | $11.57 | +51.5% | — | 34962G208 |
| — | NLS PHARMACEUTICS LTD | 143,676 | $263 | 0.0% | $5.07 | — | — | H57830137 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 3,356,782 (-15.6%) | $267,368 (+44.0%) | 9.0% | $31.23 | +109.9% | COM | 76155X100 |
| AXSM | AXSOME THERAPEUTICS INC | 45,757 (-90.6%) | $8,357 (-85.9%) | 0.3% | $85.51 | +63.3% | COM | 05464T104 |
| SEPN | SEPTERNA INC | 1,720,782 (-57.1%) | $47,975 (-36.5%) | 1.6% | $18.24 | +31.0% | COM | 81734D104 |
| ABVX | ABIVAX SA | 508,031 (-9.0%) | $68,511 (+44.6%) | 2.3% | $84.90 | — | SPONSORED ADS | 00370M103 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 879,009 (-24.3%) | $92,006 (+26.4%) | 3.1% | $27.27 | +212.9% | COM | 697947109 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3,835,886 (-32.2%) | $60,147 (+43.4%) | 2.0% | $6.80 | +98.1% | COM | 61225M102 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,488,975 (-5.4%) | $50,294 (-12.1%) | 1.7% | $33.11 | — | ADS | 45258D105 |
| TYRA | TYRA BIOSCIENCES INC | 2,127,665 (-41.7%) | $55,936 (+9.5%) | 1.9% | $16.23 | +13.2% | COM | 90240B106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 19,751,284 | $260,322 | 8.8% | $6.29 | +87.7% | CLASS A ORD | 61559X104 |
| KYMR | KYMERA THERAPEUTICS INC | 5,502,710 | $428,166 | 14.4% | $32.29 | +109.1% | COM | 501575104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,295,893 | $132,397 | 4.5% | $37.66 | -52.8% | COM | 68062P106 |
| ZYME | ZYMEWORKS INC | 3,938,641 | $103,704 | 3.5% | $7.03 | +210.4% | COM | 98985Y108 |
| XOMA | XOMA ROYALTY CORPORATION | 2,590,303 | $68,876 | 2.3% | $15.57 | +106.7% | COM NEW | 98419J206 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $59,520 | 2.0% | $20.31 | -55.6% | COM | 230031106 |
| GHRS | GH RESEARCH PLC | 8,827,712 | $112,112 | 3.8% | $18.98 | -28.2% | ORDINARY SHARES | G3855L106 |
| KURA | KURA ONCOLOGY INC | 8,617,162 | $89,532 | 3.0% | $9.56 | +9.8% | COM | 50127T109 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $26,867 | 0.9% | $19.56 | — | COM | 760273102 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,495,290 | $118,113 | 4.0% | $27.38 | +162.1% | COM | 604749101 |
| AVTX | AVALO THERAPEUTICS INC | 1,355,257 | $24,611 | 0.8% | $9.92 | +70.2% | COM NEW | 05338F306 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $9,503 | 0.3% | $4.95 | -52.0% | COM | 28617K101 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,629,289 | $34,720 | 1.2% | $13.79 | -26.4% | COM | 35104E100 |
| ACIU | AC IMMUNE SA | 19,822,436 | $62,242 | 2.1% | $4.49 | -29.8% | SHS | H00263105 |
| TCRX | TSCAN THERAPEUTICS INC | 5,226,074 | $5,226 | 0.2% | $2.41 | -40.0% | COM | 89854M101 |
| PEPG | PEPGEN INC | 1,915,000 | $12,467 | 0.4% | $1.61 | +222.0% | COM | 713317105 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $28,631 | 1.0% | $5.96 | -23.9% | COM | 344174107 |
| IMUX | IMMUNIC INC | 7,652,972 | $4,084 | 0.1% | $1.30 | -43.6% | COM | 4525EP101 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $2,401 | 0.1% | $0.85 | — | *W EXP 10/31/202 | 29286M113 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $4,139 | 0.1% | $3.62 | +140.2% | COM NEW | 88032L605 |
| XFOR | X4 PHARMACEUTICALS INC | 2,233,742 | $8,935 | 0.3% | $2.58 | +40.9% | COM NEW | 98420X202 |
| IMA | IMAGENEBIO INC | 802,102 | $5,535 | 0.2% | $13.25 | -44.1% | COM | 45175G207 |
| MOLN | MOLECULAR PARTNERS AG | 1,353,968 | $5,822 | 0.2% | $9.66 | — | ADS | 60853G106 |
| IVA | INVENTIVA SA | 686,040 | $3,190 | 0.1% | $13.70 | — | ADS | 46124U107 |